4.7 Article

The predicted impact of vaccination on human papillomavirus infections in Australia

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 123, Issue 8, Pages 1854-1863

Publisher

WILEY
DOI: 10.1002/ijc.23633

Keywords

human papillomavirus (HPV); vaccination; cervical cancer; Australia

Categories

Funding

  1. National Health and Medical Research Council Australia [440200]

Ask authors/readers for more resources

Vaccines based on human papillomavirus (HPV) 16 and 18 virus-like particles have the potential to prevent similar to 70% of cervical cancers. In Australia, public vaccination against HPV commenced in April 2007, and includes routine vaccination of females aged 12-13 years, and a 2-year school and GP-based catch-up in females age 12-26 years. The objectives of this study were to estimate initial vaccination coverage rates, to describe current patterns of sexual behavior in young females, and to predict the impact of vaccination on HPV16 infections. We reviewed early coverage data, estimating that coverage in 2007/2008 will reach 86% (feasible range 67-90%) for 12- to 13-year-old girls, with lower rates attained in older females. A review if survey data found that the median age of first intercourse in Australian females is 16 years, with similar to 90% of women sexually active at 22 years. Using these data, we performed an analysis of HPV transmission to predict the impact of vaccination on HPV infection rates. The public program is predicted to result in a reduction in the age-standardized incidence of HPV16 infections of 56% by 2010 (feasible range 48-61%), and 92% by 2050 (feasible range 76-95%). Elective vaccination of older women and vaccination of males may provide some incremental gains, but the benefits to women of vaccinating males will be less if coverage of females remains high. In conclusion, the current vaccination program is expected to result in a substantial and rapid reduction in the incidence of HPV16 in Australia. (C) 2008 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ethnic Studies

Understanding the types of racism and its effect on mental health among Muslim women in Victoria

Tahira Yeasmeen, Margaret Kelaher, Julia M. L. Brotherton

Summary: This study investigates the different types of racism experienced by Muslim and non-Muslim women living in Victoria, Australia, and the adverse mental health outcome they face after experiencing racism.

ETHNICITY & HEALTH (2023)

Article Public, Environmental & Occupational Health

The spread of coronavirus disease 2019 (COVID-19) via staff work and household networks in residential aged-care services in Victoria, Australia, May-October 2020

Sheena G. Sullivan, Giovanni Radhitio P. Sadewo, Julia M. Brotherton, Claire Kaufman, Jessie J. Goldsmith, Sarah Whiting, Logan Wu, Jose T. Canevari, Dean Lusher

Summary: Restricting visitor access and encouraging staff to work at a single site can help prevent the spread of COVID-19 in residential aged-care services. This study found that multi-site work and household contacts were the main factors contributing to the spread of the virus in aged-care facilities. Therefore, limiting staff mobility and reducing transmission through household networks are essential measures to prevent outbreaks.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Oncology

Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule

Aimee R. Kreimer, Tania Cernuschi, Helen Rees, Julia M. L. Brotherton, Carolina Porras, John Schiller

Summary: Many countries burdened by cervical cancer have not provided HPV vaccines to most eligible girls, resulting in limited access to screening and treatment. However, the increased vaccine supply and single-dose recommendation provide an opportunity to expand vaccination and prevent millions of projected cervical cancer cases.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Virology

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening

Louiza S. Veientzis, David Hawkes, Michael Caruanaa, Julia ML. Brotherton, Megan A. Smith, Lara Roeske, Khurram A. Karim, Suzanne M. Garland, C. David Wrede, Jeffery Tan, Cosette Wheeler, Philip E. Castle, Marion Saville, Karen Canfell

Summary: Australia's cervical screening program transitioned to HPV testing in December 2017 and we investigated the impact of the HPV vaccination program on HPV16/18 prevalence. The results showed a significant reduction in HPV16/18 prevalence after vaccination compared to pre-vaccination levels.

TUMOUR VIRUS RESEARCH (2023)

Article Public, Environmental & Occupational Health

The 'hot zone policy' for colorectal cancer screening presents unique risks and opportunities for rural Australia

Joachim Worthington, Jie-Bin Lew, Emily He, Kate Broun, Katina D'Onise, Paul Grogan, Karen Canfell, Eleonora Feletto

Summary: Colorectal cancer has geographic inequities in Australia, with higher mortality rates and lower participation in the National Bowel Cancer Screening Program (NBCSP) in remote and rural areas. This study describes the demographics of HZP areas and estimates the impacts of potential screening changes.

AUSTRALIAN JOURNAL OF RURAL HEALTH (2023)

Editorial Material Medicine, General & Internal

Reflections on the life and career of Professor Dame Valerie Beral AC DBE FRS FRCOG FMedSci (1943-2022)

Karen Canfell, Bette Liu, Emily Banks

MEDICAL JOURNAL OF AUSTRALIA (2023)

Article Multidisciplinary Sciences

Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study

David M. Goldsbury, Amy Vassallo, Marianne Weber, Julia Steinberg, Penelope Webb, Anna DeFazio, Karen Canfell

Summary: This study aimed to estimate the direct health system costs of women diagnosed with ovarian cancer in Australia during 2006-2013, and found that the costs are substantial. Continued investment in ovarian cancer research, including prevention, early detection, and personalized treatments, is necessary to reduce the burden of the disease.

PLOS ONE (2023)

Article Substance Abuse

Fifty-year forecasts of daily smoking prevalence: can Australia reach 5% by 2030?

Stephen Wade, Marianne F. Weber, Peter Sarich, Michael Caruana, Christina Watts, Pavla Vaneckova, Preston Ngo, Sonya Cressman, Michelle Scollo, Emily Banks, Coral E. Gartner, Paul B. Grogan, Tony Blakely, Martin C. Tammemagi, Karen Canfell

Summary: This study aimed to compare 50-year forecasts of Australian tobacco smoking rates in relation to smoking initiation and cessation trends and a national target of <= 5% adult daily prevalence by 2030. Using a compartmental model and population predictions, the study estimated smoking prevalence to 2066 and compared scenarios of different trends in initiation and cessation rates. The results showed that current trends will not achieve the target by 2030, and urgent strategies are needed to prevent initiation and facilitate cessation.

TOBACCO CONTROL (2023)

Article Biology

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia

Carolyn Nickson, Megan A. Smith, Eleonora Feletto, Louiza S. Velentzis, Kate Broun, Sabine Deij, Paul Grogan, Michaela Hall, Emily He, D. James St John, Jie-Bin Lew, Pietro Procopio, Kate T. Simms, Joachim Worthington, G. Bruce Mann, Karen Canfell, Talia Malagon

Summary: Australia introduced COVID-19 infection prevention and control measures and conducted a modelled evaluation of the impact of disruptions to cancer screening programmes. The findings showed that a 12-month screening disruption would reduce breast and colorectal cancer diagnoses, but increase cervical cancer diagnoses. Maintaining screening participation is critical to preventing an increase in the burden of cancer at a population level.

ELIFE (2023)

Article Infectious Diseases

Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2016-2019

Joanne Jackson, Nicole Sonneveld, Harunor Rashid, Larissa Karpish, Seaneen Wallace, Lisa Whop, Cyra Patel, Julia Brotherton, Han Wang, Alexandra Hendry, Brynley Hull, Katrina Clark, Stephen Lambert, Aditi Dey, Frank Beard

Summary: This report is the fifth comprehensive report by the National Centre for Immunisation Research and Surveillance (NCIRS) on vaccine preventable diseases (VPDs) and vaccination coverage in Aboriginal and Torres Strait Islander people from 2016 to 2019. It analyzes and assesses data on notifications, hospital admissions, deaths, and vaccination coverage to support service delivery, policy development, and further research. The report highlights achievements in improving the health of Aboriginal and Torres Strait Islander people through immunization programs and suggests future directions.

COMMUNICABLE DISEASES INTELLIGENCE (2023)

Article Public, Environmental & Occupational Health

Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study

Susan Yuill, Sam Egger, Megan A. Smith, Louiza Velentzis, Marion Saville, Erich Kliewer, Deborah Bateson, Karen Canfell

Summary: This study compared the participation in the National Cervical Screening Program (NCSP) between immigrants and Australian-born women. The results showed that women from New Zealand, Oceania, Middle East/North Africa, Southeast Asia, Chinese Asia, Japan/South Korea, and Southern/Central Asia had lower screening participation rates, while women from Malta and South America had higher participation rates. Non-English-speaking-at-home women were less likely to be screened. Even after living in Australia for over 20 years, immigrant groups still had lower screening rates compared to Australian-born women. This study suggests that there is room for improvement in screening participation for these groups.

JOURNAL OF MEDICAL SCREENING (2023)

Article Economics

Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia

Preston Ngo, Deme Karikios, David Goldsbury, Stephen Wade, Zarnie Lwin, Brett G. M. Hughes, Kwun M. Fong, Karen Canfell, Marianne Weber

Summary: New therapies have improved the standard of care for lung cancer since 2016, leading to a need for up-to-date evidence in health economic modelling. A discrete event simulation of advanced lung cancer treatment was developed to estimate survival outcomes and healthcare costs in the Australian setting, which can be updated as new therapies are introduced.

PHARMACOECONOMICS (2023)

Article Virology

Natural History of Oral HPV Infection among Indigenous South Australians

Xiangqun Ju, Sneha Sethi, Annika Antonsson, Joanne Hedges, Karen Canfell, Megan Smith, Gail Garvey, Richard M. Logan, Lisa M. Jamieson

Summary: This study investigated the natural history and risk factors of oral HPV infections in an Australian Indigenous cohort. Data was collected from Indigenous Australians aged 18+ years through face-to-face interviews and saliva samples. The prevalence, incidence, and persistence of oral HPV infection were high in this population, with oral sex behaviors and recreational drug use identified as risk factors for high-risk HPV infection.

VIRUSES-BASEL (2023)

Meeting Abstract Respiratory System

Economics, equity and eligibility: Using risk models versus age-smoke history categorical criteria for selection to the international lung screening trial

Sonya Cressman, Marianne Weber, Preston Ngo, Alain Tremblay, Stephen Wade, Renee Manser, Emily Stone, Sukhinder Atkar-Khattra, Deme Karikios, Cheryl Ho, Silvia Behar Harpaz, Michael Caruana, Aleisha Fernandes, Jing Yi Weng, Annette McWilliams, Renelle Meyers, John Mayo, John Yee, Ren Yuan, Henry Marshall, Kwun Fong, Stephen Lam, Karen Canfell, Martin Tammemagi

RESPIROLOGY (2023)

Article Public, Environmental & Occupational Health

Colonoscopies in Australia-how much does the National Bowel Cancer Screening Program contribute to colonoscopy use?

Joachim Worthington, Emily He, Jie-Bin Lew, James St John, Christopher Horn, Paul Grogan, Karen Canfell, Eleonora Feletto

Summary: The objective and importance of this study is to assess and project colonoscopy use in Australia and determine the impact by examining the demand generated from the National Bowel Cancer Screening Program (NBCSP). The study found that the NBCSP accounts for a modest fraction of colonoscopy use in Australia, and a better understanding of colonoscopy use not associated with the NBCSP is needed to improve outcomes and ease service pressure.

PUBLIC HEALTH RESEARCH & PRACTICE (2023)

Article Oncology

Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV

Yuxin Liu, Swati Bhardwaj, Keith Sigel, John Winters, Joseph Terlizzi, Michael M. Gaisa

Summary: This study investigated the prevalence and severity of anal HPV disease among MSM LWH under the age of 35, finding a high prevalence of HPV infection and precancer but no cases of invasive anal cancer. This supports the adoption of age-based anal cancer screening for this population.

INTERNATIONAL JOURNAL OF CANCER (2024)